+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Virulence of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates



Virulence of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates



Avian Diseases 34(1): 106-113



Virulence of six modified-live (ML) infectious laryngotracheitis (ILT) vaccine viruses was compared with that of 11 field isolates (indistinguishable from vaccine viruses by DNA restriction endonuclease analyses) by intratracheal exposure of 4-week-old, specific-pathogen-free chickens. Virulence of ILT viruses was based on an intratracheal pathogenicity index, mortality, and tracheal lesions. Intratracheal pathogenicity indices for ML vaccine viruses ranged from 0.0 to 0.14, while those for field isolates were 0.20 to 0.82. Mortality was a consistent clinical feature of field isolates; all produced mortality, with seven of the 11 isolates causing two or more deaths per inoculation group. In contrast, only one of six ML vaccine viruses produced mortality (one death per inoculation group). In general, tracheal lesions were more severe in chickens inoculated with field isolates and were produced more consistently than in chickens inoculated with vaccine viruses. These studies indicate that virulence of ILT field isolates was greater than that of ML vaccine viruses. Together with previous restriction endonuclease analyses, these findings suggest the possibility that field isolates originated from ML vaccine viruses through reversion to parental-type virulence.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 068556709

Download citation: RISBibTeXText

PMID: 2157386


Related references

Virulence of Infectious Laryngotracheitis Viruses: Comparison of Modified-Live Vaccine Viruses and North Carolina Field Isolates. Avian Diseases 34(1): 106-113, 1990

Virulence of infectious laryngotracheitis viruses comparison of modified live vaccine viruses and north carolina usa field isolates. Avian Diseases 34(1): 106-113, 1990

Restriction endonuclease analysis of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates. Avian Diseases 33(2): 316-323, 1989

Comparison of virulence and restriction endonuclease cleavage patterns of infectious laryngotracheitis viruses isolated in Korea. Avian Pathology 30(4): 337-344, 2001

Increased Virulence of Modified-Live Infectious Laryngotracheitis Vaccine Virus Following Bird-to-Bird Passage. Avian Diseases 35(2): 348-355, 1991

Antigenic comparison of field isolates of infectious bursal disease virus with vaccine viruses by reciprocal serum neutralisation test. Indian Journal of Virology 12(1): 25-28, 1996

Efficacy of live vaccine viruses against standard and variant infectious bursal disease virus isolates. Journal of the American Veterinary Medical Association 194(12): 1808, 1989

Studies on the live-virus vaccine against infectious laryngotracheitis of chickens. II. Evaluation of the tissue-culture-modified strain C7 in laboratory and field trials. Avian Diseases 28(2): 323-330, 1984

Distinguishing infectious bronchitis vaccine viruses from field viruses in commercial poultry. Poultry Science 87: 155-155, 2008

Protection conferred by live infectious bronchitis vaccine viruses against variant Middle East IS/885/00-like and IS/1494/06-like isolates in commercial broiler chicks. Veterinary Record Open 2(2): E000111, 2015

RFLP analysis of recent Northern Ireland isolates of infectious laryngotracheitis virus: comparison with vaccine virus and field isolates from England, Scotland and the Republic of Ireland. Avian Pathology 29(1): 57-62, 2000

Characterization of field and vaccine infectious bursal disease viruses from Nigeria revealing possible virulence and regional markers in the VP2 minor hydrophilic peaks. Avian Pathology 42(5): 420-433, 2013

Study of the virulence and cross-neutralization capability of recent porcine parvovirus field isolates and vaccine viruses in experimentally infected pregnant gilts. Journal of General Virology 88(Pt 2): 420-427, 2007

The development of a vaccine against avian infectious laryngotracheitis. IV. Immunization of chickens with a modified laryngotracheitis vaccine in the drinking water. Avian Diseases 15(2): 413-417, 1971

Immunizing characteristics of a tissue-culture-origin modified live-virus ocular vaccine for infectious laryngotracheitis. Avian Diseases 15(2): 277-283, 1971